| Identification | Back Directory | [Name]
(8S-cis)-8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-alpha-L-arabino-hexopyranosyl]oxy]naphthacene-5,12-dione | [CAS]
57918-22-6 | [Synonyms]
Epirubicin Impurity 7
4'-epi-N-Trifluoroacetyldaunorubicin
(8S)-8β-Acetyl-7,8,9,10-tetrahydro-6,8α,11-trihydroxy-1-methoxy-10α-[3-(trifluoroacetylamino)-2,3,6-trideoxy-α-L-arabino-hexopyranosyloxy]-5,12-naphthacenedione
(8S,10S)-8-Acetyl-10-[[3-(trifluoroacetylamino)-2,3,6-trideoxy-α-L-arabino-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione
5,12-Naphthacenedione, 8-acetyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-10-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-α-L-arabino-hexopyranosyl]oxy]-, (8S,10S)- | [EINECS(EC#)]
261-015-8 | [Molecular Formula]
C29H28F3NO11 | [MOL File]
57918-22-6.mol | [Molecular Weight]
623.53 |
| Hazard Information | Back Directory | [Uses]
4''-epi-N-Trifluoroacetyldaunorubicin is an intermediate used in the synthesis of 4’-epi-Daunorubicin (D194490), which is a Daunorubicin (D194500) impurity. Daunomycin analog antitumor. |
|
|